DISCLOSEDT+30
Groww Mutual Fund (scheme NI)
Strides Pharma Science Ltd · NSE
1,176 sh · ₹12.05 L
Filed 31 Jul 2026AMFI portfolioview source
Aditya Birla Sun Life Value Fund
0.6% of their portfolio
₹40.04 Cr
3,66,350 sh
Groww Mutual Fund (scheme IB18)
0.0% of their portfolio
₹12.84 L
1,175 sh
Groww Mutual Fund (scheme NI)
0.0% of their portfolio
₹12.05 L
1,176 sh
Mukul Agrawal
Investor
—
10,28,750 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— +0.1pp
Groww Mutual Fund (scheme NI)
Strides Pharma Science Ltd · NSE
1,176 sh · ₹12.05 L
Mukul Agrawal
Strides Pharma Science Ltd · NSE
10,28,750 sh
Groww Mutual Fund (scheme IB18)
Strides Pharma Science Ltd · NSE
1,175 sh · ₹12.84 L
Aditya Birla Sun Life Value Fund
Strides Pharma Science Ltd · NSE
3,66,350 sh · ₹40.04 Cr
Groww Mutual Fund (scheme NI)
Strides Pharma Science Ltd · NSE
1,168 sh · ₹12.99 L
Aditya Birla Sun Life Value Fund
Strides Pharma Science Ltd · NSE
3,66,350 sh · ₹37.98 Cr
Mukul Agrawal
Strides Pharma Science Ltd · NSE
10,66,000 sh
Mukul Agrawal
Strides Pharma Science Ltd · NSE
10,66,000 sh
Mukul Agrawal
Strides Pharma Science Ltd · NSE
10,66,000 sh
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
18 announcements on record for this company.
Promoter holding by quarter: Jun 2025 28.3%, Sep 2025 27.9%, Dec 2025 27.9%, Mar 2026 27.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.8pp
FII holding by quarter: Jun 2025 28.0%, Sep 2025 28.5%, Dec 2025 29.5%, Mar 2026 28.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +1.4pp
DII holding by quarter: Jun 2025 13.3%, Sep 2025 13.0%, Dec 2025 13.0%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 8.8%, Sep 2025 8.5%, Dec 2025 8.6%, Mar 2026 8.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Mukul Agrawal
Strides Pharma Science Ltd · NSE
10,66,000 sh
Ownership by quarter
Promoter
— +0.1pp
Promoter holding by quarter: Jun 2025 28.3%, Sep 2025 27.9%, Dec 2025 27.9%, Mar 2026 27.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.8pp
FII holding by quarter: Jun 2025 28.0%, Sep 2025 28.5%, Dec 2025 29.5%, Mar 2026 28.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +1.4pp
DII holding by quarter: Jun 2025 13.3%, Sep 2025 13.0%, Dec 2025 13.0%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 8.8%, Sep 2025 8.5%, Dec 2025 8.6%, Mar 2026 8.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
18 announcements on record for this company.